A Randomized Open Label Trial of Oral Sirolimus for Decrease of Stenosis in Arteriovenous Fistula in Hemo-dialysis Patients When Compared With Standard Therapy
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms SAVE
- 08 Sep 2016 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
- 08 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 17 Apr 2015 New trial record